216 related articles for article (PubMed ID: 25326691)
1. Mind matters: placebo enhances reward learning in Parkinson's disease.
Schmidt L; Braun EK; Wager TD; Shohamy D
Nat Neurosci; 2014 Dec; 17(12):1793-7. PubMed ID: 25326691
[TBL] [Abstract][Full Text] [Related]
2. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
3. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease.
Sharp ME; Duncan K; Foerde K; Shohamy D
Brain; 2020 Aug; 143(8):2519-2531. PubMed ID: 32844197
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
5. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.
Petersen K; Van Wouwe N; Stark A; Lin YC; Kang H; Trujillo-Diaz P; Kessler R; Zald D; Donahue MJ; Claassen DO
Hum Brain Mapp; 2018 Jan; 39(1):509-521. PubMed ID: 29086460
[TBL] [Abstract][Full Text] [Related]
6. Placebo effect and dopamine release.
de la Fuente-Fernández R; Lidstone S; Stoessl AJ
J Neural Transm Suppl; 2006; (70):415-8. PubMed ID: 17017561
[TBL] [Abstract][Full Text] [Related]
7. Greater striatal responses to medication in Parkinson׳s disease are associated with better task-switching but worse reward performance.
Aarts E; Nusselein AA; Smittenaar P; Helmich RC; Bloem BR; Cools R
Neuropsychologia; 2014 Sep; 62():390-7. PubMed ID: 24912070
[TBL] [Abstract][Full Text] [Related]
8. Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD.
Udupa K; Fox SH
Mov Disord; 2015 May; 30(6):786. PubMed ID: 25855005
[No Abstract] [Full Text] [Related]
9. Dopamine selectively remediates 'model-based' reward learning: a computational approach.
Sharp ME; Foerde K; Daw ND; Shohamy D
Brain; 2016 Feb; 139(Pt 2):355-64. PubMed ID: 26685155
[TBL] [Abstract][Full Text] [Related]
10. Effects of expectation on placebo-induced dopamine release in Parkinson disease.
Lidstone SC; Schulzer M; Dinelle K; Mak E; Sossi V; Ruth TJ; de la Fuente-Fernández R; Phillips AG; Stoessl AJ
Arch Gen Psychiatry; 2010 Aug; 67(8):857-65. PubMed ID: 20679593
[TBL] [Abstract][Full Text] [Related]
11. Reward processing dysfunction in ventral striatum and orbitofrontal cortex in Parkinson's disease.
du Plessis S; Bossert M; Vink M; van den Heuvel L; Bardien S; Emsley R; Buckle C; Seedat S; Carr J
Parkinsonism Relat Disord; 2018 Mar; 48():82-88. PubMed ID: 29307561
[TBL] [Abstract][Full Text] [Related]
12. Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease.
Shiner T; Seymour B; Wunderlich K; Hill C; Bhatia KP; Dayan P; Dolan RJ
Brain; 2012 Jun; 135(Pt 6):1871-83. PubMed ID: 22508958
[TBL] [Abstract][Full Text] [Related]
13. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
[TBL] [Abstract][Full Text] [Related]
14. Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease.
Muhammed K; Manohar S; Ben Yehuda M; Chong TT; Tofaris G; Lennox G; Bogdanovic M; Hu M; Husain M
Brain; 2016 Oct; 139(Pt 10):2706-2721. PubMed ID: 27452600
[TBL] [Abstract][Full Text] [Related]
15. Distinct alterations in Parkinson's medication-state and disease-state connectivity.
Ng B; Varoquaux G; Poline JB; Thirion B; Greicius MD; Poston KL
Neuroimage Clin; 2017; 16():575-585. PubMed ID: 28971008
[TBL] [Abstract][Full Text] [Related]
16. Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease.
van der Vegt JP; Hulme OJ; Zittel S; Madsen KH; Weiss MM; Buhmann C; Bloem BR; Münchau A; Siebner HR
Brain; 2013 Apr; 136(Pt 4):1192-203. PubMed ID: 23442226
[TBL] [Abstract][Full Text] [Related]
17. Impaired context-sensitive adjustment of behaviour in Parkinson's disease patients tested on and off medication: An fMRI study.
Trempler I; Bürkner PC; El-Sourani N; Binder E; Reker P; Fink GR; Schubotz RI
Neuroimage; 2020 May; 212():116674. PubMed ID: 32097724
[TBL] [Abstract][Full Text] [Related]
18. Selective impairment of prediction error signaling in human dorsolateral but not ventral striatum in Parkinson's disease patients: evidence from a model-based fMRI study.
Schonberg T; O'Doherty JP; Joel D; Inzelberg R; Segev Y; Daw ND
Neuroimage; 2010 Jan; 49(1):772-81. PubMed ID: 19682583
[TBL] [Abstract][Full Text] [Related]
19. Reward processing abnormalities in Parkinson's disease.
Kapogiannis D; Mooshagian E; Campion P; Grafman J; Zimmermann TJ; Ladt KC; Wassermann EM
Mov Disord; 2011 Jul; 26(8):1451-7. PubMed ID: 21538525
[TBL] [Abstract][Full Text] [Related]
20. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.
Bódi N; Kéri S; Nagy H; Moustafa A; Myers CE; Daw N; Dibó G; Takáts A; Bereczki D; Gluck MA
Brain; 2009 Sep; 132(Pt 9):2385-95. PubMed ID: 19416950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
